| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 7e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |